Multaq trial halted

July 11, 2011

SANOFI-Aventis has called a halt to a new clinical trial of its heart drug Multaq (dronedarone), after an independent safety monitor reported a “significant increase in cardiovascular events” in the trial group taking the drug. The company had hoped the trial would lead to an expansion of the drug’s approval to treat patients with permanent atrial fibrillation (AF). Multaq is approved in the EU and US for the treatment of nonpermanent AF. “We are notifying regulatory authorities in all countries where the product is approved or under review on this matter,” said Sanofi’s CMO Jean-Pierre Lehner. “We remain committed to Multaq as an essential treatment option for non-permanent AF patients,” he added.

The above article was sent to subscribers in Pharmacy Daily's issue from 11 Jul 11
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Jul 11

Other recent headlines

Joint call for $19 co-payment
Thursday | Mar 13 2025
LEADING health and community voices including the Pharmacy Guild of Australia are calling for bipartisan support to reduce the maximum out-of-pocket cost of prescription medicine to $19.

Pharmacists thanked for stepping up
Thursday | Mar 13 2025
TODAY is Thank Your Pharmacist Day, and the Pharmaceutical Society of Australia (PSA) is celebrating the nation’s 40,000 pharmacists, recognising their dedication and impact across all areas of practice and in all corners of the country.

Editor’s Choice: Happy Kat post-partum personal care
Thursday | Mar 13 2025
HAPPY Kat is the first pharmacy-ready postpartum recovery pack designed to make post-birth healing simple, accessible and stress-free.

SEARCH PHARMACY DAILY

Featured video
MORE VIDEOS

Recent issues

PD for Thu 13 Mar 2025
PD for Wed 12 Mar 2025
PD for Tue 11 Mar 2025
PD for Mon 10 Mar 2025
PD for Fri 07 Mar 2025
SEE MORE ISSUES

INDUSTRY JOB VACANCIES

Pharmacist in Charge – SA
Pharmacist Manager – WA
Compounding Pharmacist – Melbourne
Pharmacist in Charge – QLD North
Pharmacist – Sydney North
SEE MORE JOBS

Pharmacy Daily is Australia's favourite online publication dedicated to the pharmacy industry. The publication launched in March 2007 and is distributed every day by email to pharmacists across the country.

PHARMACY DAILY NEWS
Headlines

Jobs

New Products

Events Calendar

FEEDS
News Items RSS feed

PD Issues RSS feed

All content RSS feed

Content & Media
Pharmacy Daily TV

OUR SITES
Sitemap

Travel Daily

Travel Bulletin

Cruise Weekly

Business Events News

Pharmacy Daily

ADVERTISE WITH US
Advertise in Pharmacy Daily

Privacy

ADMIN
Log in

SUBSCRIBE
Sign up for FREE

Subscription Information

"Water, air, and cleanness are the chief articles in my pharmacy." - Napoleon Bonaparte

Copyright © 2025 Pharmacy Daily

Subscribe to Pharmacy Daily now!

FREE Pharmacy Daily subscription - never miss another story!

Name*
First Last
Email*

Profession
Company

Address
City State / Province / Region ZIP / Postal Code Country

By submitting this form I hereby certify that I understand that Pharmacy Daily is a publication for health professionals.
Email
This field is for validation purposes and should be left unchanged.

to top

Pharmacy Daily | Multaq trial halted

Multaq trial halted

Other recent headlines

Joint call for $19 co-payment

Pharmacists thanked for stepping up

Editor’s Choice: Happy Kat post-partum personal care

SEARCH PHARMACY DAILY

Featured video

Recent issues

INDUSTRY JOB VACANCIES